{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T10:33:35Z","timestamp":1788518015185,"version":"build-2803163510"},"reference-count":110,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:00:00Z","timestamp":1750809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Programme Hospitaller de Recherche Clinique (PHRC)\u20142017 (French Ministry of Health)"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Recently, marketing authorizations were granted by the Federal Drug Administration (FDA) for pegcetacoplan and avacincaptad pegol, which inhibit C3 and C5 complement components, respectively. These two drugs were demonstrated to slow down the growth of atrophic areas in the retina. These authorizations represent a huge breakthrough for patients suffering from geographic atrophy (GA), the late stage of the dry form of Age-related Macular Degeneration (AMD). Until then, no treatment was available to treat this blinding disease. However, these two new compounds inhibiting the complement system are still not available for patients outside of the United States, and they are not devoid of drawbacks, including a poor effect on vision improvement, an increased risk of occurrence of the neovascular form of AMD and the burden of patients receiving recurrent intravitreal injections. Thus, the important medical need posed by GA remains incompletely answered, and new therapeutic options with alternative modes of action are still required. Oxidative stress and inflammation are two major potential targets to limit the progression of atrophic retinal lesions. Dimethyl fumarate, dimethyl itaconate and other activators of the transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2) display antioxidants and immunomodulatory properties that have shown evidence of efficacy in in vitro and in vivo models of dry AMD. Tecfidera\u00ae, whose active principle is dimethyl fumarate, is already commercialized for the treatment of autoimmune diseases such as multiple sclerosis and psoriasis. The aim of this review is to present the rationale and the design of the clinical trial we initiated to test the effectiveness and safety of repurposing Tecfidera\u00ae, which could represent a new therapeutic alternative in patients with the dry form of AMD.<\/jats:p>","DOI":"10.3390\/ijms26136112","type":"journal-article","created":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T06:55:13Z","timestamp":1750920913000},"page":"6112","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Repurposing Dimethyl Fumarate Targeting Nrf2 to Slow Down the Growth of Areas of Geographic Atrophy"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8733-8503","authenticated-orcid":false,"given":"Serge","family":"Camelo","sequence":"first","affiliation":[{"name":"Independent Researcher, 193 Avenue du Pr\u00e9sident Wilson, 93210 Saint-Denis, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0140-6736(18)31550-2","article-title":"Age-related macular degeneration","volume":"392","author":"Mitchell","year":"2018","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"6067","DOI":"10.1097\/MS9.0000000000001466","article-title":"Advancements in the treatment of geographic atrophy: Focus on pegcetacoplan in age-related macular degeneration","volume":"85","author":"Nadeem","year":"2023","journal-title":"Ann. Med. Surg."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1007\/s40265-023-01948-8","article-title":"Avacincaptad Pegol: First Approval","volume":"83","author":"Kang","year":"2023","journal-title":"Drugs"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ophtha.2019.07.011","article-title":"Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Randomized Phase 2 Trial","volume":"127","author":"Liao","year":"2020","journal-title":"Ophthalmology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/S0140-6736(23)01520-9","article-title":"Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): Two multicentre, randomised, double-masked, sham-controlled, phase 3 trials","volume":"402","author":"Heier","year":"2023","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.ophtha.2021.02.025","article-title":"Characterizing New-Onset Exudation in the Randomized Phase 2 FILLY Trial of Complement Inhibitor Pegcetacoplan for Geographic Atrophy","volume":"128","author":"Wykoff","year":"2021","journal-title":"Ophthalmology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ophtha.2020.08.027","article-title":"C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration: A Randomized Pivotal Phase 2\/3 Trial","volume":"128","author":"Jaffe","year":"2021","journal-title":"Ophthalmology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/S0140-6736(23)01583-0","article-title":"Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial","volume":"402","author":"Khanani","year":"2023","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ajo.2024.02.021","article-title":"Drug Approval for the Treatment of Geographic Atrophy: How We Got Here and Where We Need to Go","volume":"263","author":"Csaky","year":"2024","journal-title":"Am. J. Ophthalmol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Biarnes, M., Garrell-Salat, X., Gomez-Benlloch, A., Guarro, M., Londono, G., Lopez, E., Ruiz, S., Vazquez, M., and Sararols, L. (2023). Methodological Appraisal of Phase 3 Clinical Trials in Geographic Atrophy. Biomedicines, 11.","DOI":"10.3390\/biomedicines11061548"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Khan, A.H., Chowers, I., and Lotery, A.J. (2023). Beyond the Complement Cascade: Insights into Systemic Immunosenescence and Inflammaging in Age-Related Macular Degeneration and Current Barriers to Treatment. Cells, 12.","DOI":"10.3390\/cells12131708"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Lin, J.B., Halawa, O.A., Miller, J.W., and Vavvas, D.G. (2021). Complement Inhibition for Geographic Atrophy: A Tempting Target with Mixed Results. J. Clin. Med., 10.","DOI":"10.3390\/jcm10132890"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"100057","DOI":"10.1016\/j.xops.2021.100057","article-title":"Local Complement Inhibition for Geographic Atrophy in Age-Related Macular Degeneration: Prospects, Challenges, and Unanswered Questions","volume":"1","author":"Keenan","year":"2021","journal-title":"Ophthalmol. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1755-3768.2011.02179.x","article-title":"Molecular mechanisms of retinal pigment epithelium damage and development of age-related macular degeneration","volume":"90","author":"Kinnunen","year":"2012","journal-title":"Acta Ophthalmol."},{"key":"ref_15","first-page":"133","article-title":"The role of the complement system in age-related macular degeneration","volume":"111","author":"Weber","year":"2014","journal-title":"Dtsch. Arztebl. Int."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1126\/science.1133811","article-title":"A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration","volume":"314","author":"Yang","year":"2006","journal-title":"Science"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1126\/science.1133807","article-title":"HTRA1 promoter polymorphism in wet age-related macular degeneration","volume":"314","author":"Dewan","year":"2006","journal-title":"Science"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1167\/iovs.05-0719","article-title":"Cigarette smoke-related oxidants and the development of sub-RPE deposits in an experimental animal model of dry AMD","volume":"47","author":"Suner","year":"2006","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.addbeh.2009.05.015","article-title":"Smoking history and the incidence of age-related macular degeneration--results from the Muenster Aging and Retina Study (MARS) cohort and systematic review and meta-analysis of observational longitudinal studies","volume":"34","author":"Neuner","year":"2009","journal-title":"Addict. Behav."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Kushwah, N., Bora, K., Maurya, M., Pavlovich, M.C., and Chen, J. (2023). Oxidative Stress and Antioxidants in Age-Related Macular Degeneration. Antioxidants, 12.","DOI":"10.3390\/antiox12071379"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"100858","DOI":"10.1016\/j.preteyeres.2020.100858","article-title":"Mechanisms of mitochondrial dysfunction and their impact on age-related macular degeneration","volume":"79","author":"Kaarniranta","year":"2020","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Tong, Y., Zhang, Z., and Wang, S. (2022). Role of Mitochondria in Retinal Pigment Epithelial Aging and Degeneration. Front. Aging, 3.","DOI":"10.3389\/fragi.2022.926627"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Lenin, R.R., Koh, Y.H., Zhang, Z., Yeo, Y.Z., Parikh, B.H., Seah, I., Wong, W., and Su, X. (2023). Dysfunctional Autophagy, Proteostasis, and Mitochondria as a Prelude to Age-Related Macular Degeneration. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24108763"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.preteyeres.2017.03.002","article-title":"The impact of oxidative stress and inflammation on RPE degeneration in non-neovascular AMD","volume":"60","author":"Datta","year":"2017","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/nri3459","article-title":"Immunology of age-related macular degeneration","volume":"13","author":"Ambati","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1002\/emmm.201302692","article-title":"CCR2(+) monocytes infiltrate atrophic lesions in age-related macular disease and mediate photoreceptor degeneration in experimental subretinal inflammation in Cx3cr1 deficient mice","volume":"5","author":"Sennlaub","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Wong, J.H.C., Ma, J.Y.W., Jobling, A.I., Brandli, A., Greferath, U., Fletcher, E.L., and Vessey, K.A. (2022). Exploring the pathogenesis of age-related macular degeneration: A review of the interplay between retinal pigment epithelium dysfunction and the innate immune system. Front. Neurosci., 16.","DOI":"10.3389\/fnins.2022.1009599"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/978-1-4614-3209-8_25","article-title":"Molecular pathology of macrophages and interleukin-17 in age-related macular degeneration","volume":"801","author":"Chan","year":"2014","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_29","first-page":"532487","article-title":"Potential Sources and Roles of Adaptive Immunity in Age-Related Macular Degeneration: Shall We Rename AMD into Autoimmune Macular Disease?","volume":"2014","author":"Camelo","year":"2014","journal-title":"Autoimmune Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000446587","article-title":"Association of Choroidal Interleukin-17-Producing T Lymphocytes and Macrophages with Geographic Atrophy","volume":"236","author":"Camelo","year":"2016","journal-title":"Ophthalmologica"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"939","DOI":"10.2147\/CIA.S463297","article-title":"Age-Related Macular Degeneration: A Disease of Cellular Senescence and Dysregulated Immune Homeostasis","volume":"19","author":"Li","year":"2024","journal-title":"Clin. Interv. Aging"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Basyal, D., Lee, S., and Kim, H.J. (2024). Antioxidants and Mechanistic Insights for Managing Dry Age-Related Macular Degeneration. Antioxidants, 13.","DOI":"10.3390\/antiox13050568"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Bellezza, I. (2018). Oxidative Stress in Age-Related Macular Degeneration: Nrf2 as Therapeutic Target. Front. Pharmacol., 9.","DOI":"10.3389\/fphar.2018.01280"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1167\/iovs.03-0351","article-title":"Oxidative stress affects the junctional integrity of retinal pigment epithelial cells","volume":"45","author":"Bailey","year":"2004","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S1350-9462(99)00009-9","article-title":"Oxidative damage and protection of the RPE","volume":"19","author":"Cai","year":"2000","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2174\/1874205X01610010083","article-title":"Oxidative Stress Induces Senescence in Cultured RPE Cells","volume":"10","author":"Aryan","year":"2016","journal-title":"Open Neurol. J."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.2741\/4033","article-title":"Oxidative stress: The achilles\u2019 heel of neurodegenerative diseases of the retina","volume":"17","author":"Cai","year":"2012","journal-title":"Front. Biosci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/978-1-4419-1399-9_20","article-title":"Mitochondrial decay and impairment of antioxidant defenses in aging RPE cells","volume":"664","author":"He","year":"2010","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_40","first-page":"1275","article-title":"Age-related macular degeneration: The molecular link between oxidative damage, tissue-specific inflammation and outer retinal disease: The Proctor lecture","volume":"51","author":"Hollyfield","year":"2010","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"15244","DOI":"10.1074\/jbc.M113.540633","article-title":"Transcription factors NRF2 and NF-kappaB are coordinated effectors of the Rho family, GTP-binding protein RAC1 during inflammation","volume":"289","author":"Cuadrado","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s00204-019-02409-6","article-title":"Toxicity of blue led light and A2E is associated to mitochondrial dynamics impairment in ARPE-19 cells: Implications for age-related macular degeneration","volume":"93","author":"Alaimo","year":"2019","journal-title":"Arch. Toxicol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.mam.2012.03.006","article-title":"How does the macula protect itself from oxidative stress?","volume":"33","author":"Handa","year":"2012","journal-title":"Mol. Aspects Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0014-4835(03)00029-0","article-title":"Human RPE-monocyte co-culture induces chemokine gene expression through activation of MAPK and NIK cascade","volume":"76","author":"Bian","year":"2003","journal-title":"Exp. Eye Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e16490","DOI":"10.7554\/eLife.16490","article-title":"Subretinal mononuclear phagocytes induce cone segment loss via IL-1beta","volume":"5","author":"Eandi","year":"2016","journal-title":"Elife"},{"key":"ref_46","first-page":"718","article-title":"Altered cytokine profiles of human retinal pigment epithelium: Oxidant injury and replicative senescence","volume":"19","author":"Cao","year":"2013","journal-title":"Mol. Vis."},{"key":"ref_47","first-page":"294","article-title":"Repurposing an orally available drug for the treatment of geographic atrophy","volume":"22","author":"Ahmed","year":"2016","journal-title":"Mol. Vis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/nm1709","article-title":"Oxidative damage-induced inflammation initiates age-related macular degeneration","volume":"14","author":"Hollyfield","year":"2008","journal-title":"Nat. Med."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Cruz-Guilloty, F., Saeed, A.M., Duffort, S., Cano, M., Ebrahimi, K.B., Ballmick, A., Tan, Y., Wang, H., Laird, J.M., and Salomon, R.G. (2014). T cells and macrophages responding to oxidative damage cooperate in pathogenesis of a mouse model of age-related macular degeneration. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0088201"},{"key":"ref_50","first-page":"1051","article-title":"Thinning of the RPE and choroid associated with T lymphocyte recruitment in aged and light-challenged mice","volume":"21","author":"Camelo","year":"2015","journal-title":"Mol. Vis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00018-019-03419-4","article-title":"The role of lymphocytes and phagocytes in age-related macular degeneration (AMD)","volume":"77","author":"Behnke","year":"2020","journal-title":"Cell Mol. Life Sci."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1016\/j.ophtha.2013.04.014","article-title":"Age-related macular degeneration is associated with increased proportion of CD56(+) T cells in peripheral blood","volume":"120","author":"Faber","year":"2013","journal-title":"Ophthalmology"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"7480","DOI":"10.1167\/iovs.15-17251","article-title":"Modeling the Dynamic AMD-Associated Chronic Oxidative Stress Changes in Human ESC and iPSC-Derived RPE Cells","volume":"56","author":"Garcia","year":"2015","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1007\/s00018-016-2223-0","article-title":"Role of Nrf2\/HO-1 system in development, oxidative stress response and diseases: An evolutionarily conserved mechanism","volume":"73","author":"Loboda","year":"2016","journal-title":"Cell Mol. Life Sci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41573-018-0008-x","article-title":"Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases","volume":"18","author":"Cuadrado","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.bbamcr.2018.02.010","article-title":"Nrf2-Keap1 signaling in oxidative and reductive stress","volume":"1865","author":"Bellezza","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.exer.2016.12.001","article-title":"Nrf2 protects photoreceptor cells from photo-oxidative stress induced by blue light","volume":"154","author":"Chen","year":"2017","journal-title":"Exp. Eye Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1089\/ars.2015.6615","article-title":"Nuclear Factor E2-Related Factor-2 Negatively Regulates NLRP3 Inflammasome Activity by Inhibiting Reactive Oxygen Species-Induced NLRP3 Priming","volume":"26","author":"Liu","year":"2017","journal-title":"Antioxid. Redox Signal"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"102247","DOI":"10.1016\/j.coi.2022.102247","article-title":"Regulation of innate immunity by Nrf2","volume":"78","author":"Laguette","year":"2022","journal-title":"Curr. Opin. Immunol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"11624","DOI":"10.1038\/ncomms11624","article-title":"Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription","volume":"7","author":"Kobayashi","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Gureev, A.P., Shaforostova, E.A., and Popov, V.N. (2019). Regulation of Mitochondrial Biogenesis as a Way for Active Longevity: Interaction Between the Nrf2 and PGC-1alpha Signaling Pathways. Front. Genet., 10.","DOI":"10.3389\/fgene.2019.00435"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Zhao, Z., Chen, Y., Wang, J., Sternberg, P., Freeman, M.L., Grossniklaus, H.E., and Cai, J. (2011). Age-related retinopathy in NRF2-deficient mice. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0019456"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.freeradbiomed.2014.01.015","article-title":"Nrf2 signaling modulates cigarette smoke-induced complement activation in retinal pigmented epithelial cells","volume":"70","author":"Wang","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.visres.2009.08.018","article-title":"Cigarette smoking, oxidative stress, the anti-oxidant response through Nrf2 signaling, and Age-related Macular Degeneration","volume":"50","author":"Cano","year":"2010","journal-title":"Vision. Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"6580","DOI":"10.1167\/iovs.14-15166","article-title":"gammadelta T cells as a major source of IL-17 production during age-dependent RPE degeneration","volume":"55","author":"Zhao","year":"2014","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"108061","DOI":"10.1016\/j.exer.2020.108061","article-title":"CXCR5\/NRF2 double knockout mice develop retinal degeneration phenotype at early adult age","volume":"196","author":"Huang","year":"2020","journal-title":"Exp. Eye Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"7469326","DOI":"10.1155\/2016\/7469326","article-title":"Nrf2 Is an Attractive Therapeutic Target for Retinal Diseases","volume":"2016","author":"Nakagami","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1703810","DOI":"10.1155\/2017\/1703810","article-title":"Involvement of Nrf2 in Ocular Diseases","volume":"2017","author":"Batliwala","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Catanzaro, M., Lanni, C., Basagni, F., Rosini, M., Govoni, S., and Amadio, M. (2020). Eye-Light on Age-Related Macular Degeneration: Targeting Nrf2-Pathway as a Novel Therapeutic Strategy for Retinal Pigment Epithelium. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.00844"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.lfs.2016.05.006","article-title":"Lycopene inhibits ICAM-1 expression and NF-kappaB activation by Nrf2-regulated cell redox state in human retinal pigment epithelial cells","volume":"155","author":"Yang","year":"2016","journal-title":"Life Sci."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1074\/jbc.M114.603738","article-title":"Activation of the UPR protects against cigarette smoke-induced RPE apoptosis through up-regulation of Nrf2","volume":"290","author":"Huang","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1080\/21691401.2019.1608217","article-title":"Quercetin protect cigarette smoke extracts induced inflammation and apoptosis in RPE cells","volume":"47","author":"Zhu","year":"2019","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Sahin, E., Orhan, C., Sahin, N., Padigaru, M., Morde, A., Lal, M., Dhavan, N., Erten, F., Bilgic, A.A., and Ozercan, I.H. (2023). Lutein\/Zeaxanthin Isomers and Quercetagetin Combination Safeguards the Retina from Photo-Oxidative Damage by Modulating Neuroplasticity Markers and the Nrf2 Pathway. Pharmaceuticals, 16.","DOI":"10.3390\/ph16111543"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"e1218","DOI":"10.1038\/cddis.2014.190","article-title":"Zeaxanthin induces Nrf2-mediated phase II enzymes in protection of cell death","volume":"5","author":"Zou","year":"2014","journal-title":"Cell Death Dis."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"5944","DOI":"10.1021\/acs.jafc.7b01929","article-title":"Lutein Activates the Transcription Factor Nrf2 in Human Retinal Pigment Epithelial Cells","volume":"65","author":"Frede","year":"2017","journal-title":"J. Agric. Food Chem."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Eisenhauer, B., Natoli, S., Liew, G., and Flood, V.M. (2017). Lutein and Zeaxanthin-Food Sources, Bioavailability and Dietary Variety in Age-Related Macular Degeneration Protection. Nutrients, 9.","DOI":"10.3390\/nu9020120"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ophtha.2024.07.014","article-title":"Oral Antioxidant and Lutein\/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration","volume":"132","author":"Keenan","year":"2024","journal-title":"Ophthalmology"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jgr.2022.09.007","article-title":"Nrf2-mediated activation of HO-1 is required in the blocking effect of compound K, a ginseng saponin metabolite, against oxidative stress damage in ARPE-19 human retinal pigment epithelial cells","volume":"47","author":"Park","year":"2023","journal-title":"J. Ginseng Res."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Shi, X., Zhou, H., Wei, J., Mo, W., Li, Q., and Lv, X. (2022). The signaling pathways and therapeutic potential of itaconate to alleviate inflammation and oxidative stress in inflammatory diseases. Redox Biol., 58.","DOI":"10.1016\/j.redox.2022.102553"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature25986","article-title":"Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1","volume":"556","author":"Mills","year":"2018","journal-title":"Nature"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/imm.13875","article-title":"Metabolic Regulation of Inflammation: Exploring the Potential Benefits of Itaconate in Autoimmune Disorders","volume":"174","author":"Luo","year":"2024","journal-title":"Immunology"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cytogfr.2024.07.001","article-title":"The anti-inflammatory effects of itaconate and its derivatives in neurological disorders","volume":"78","author":"Kong","year":"2024","journal-title":"Cytokine Growth Factor. Rev."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1080\/10286020.2021.1949303","article-title":"A comparison study between dimethyl itaconate and dimethyl fumarate in electrophilicity, Nrf2 activation, and anti-inflammation in vitro","volume":"24","author":"Zhang","year":"2022","journal-title":"J. Asian Nat. Prod. Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"12311","DOI":"10.3892\/mmr.2021.12311","article-title":"Dimethyl itaconate inhibits LPS-induced microglia inflammation and inflammasome-mediated pyroptosis via inducing autophagy and regulating the Nrf-2\/HO-1 signaling pathway","volume":"24","author":"Yang","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bbrc.2021.03.113","article-title":"Protective effects of 4-octyl itaconate against inflammatory response in angiotensin II-induced oxidative stress in human primary retinal pigment epithelium","volume":"557","author":"Fu","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"e23607","DOI":"10.1096\/fj.202302293RR","article-title":"Dimethyl itaconate inhibits antigen-specific Th17 cell responses and autoimmune inflammation via modulating NRF2\/STAT3 signaling","volume":"38","author":"Wang","year":"2024","journal-title":"FASEB J."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s10753-023-01950-y","article-title":"4-Octyl Itaconate Inhibits Proinflammatory Cytokine Production in Behcet\u2019s Uveitis and Experimental Autoimmune Uveitis","volume":"47","author":"Wang","year":"2024","journal-title":"Inflammation"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1167\/iovs.15-17703","article-title":"Targeting the Nrf2 Signaling Pathway in the Retina With a Gene-Delivered Secretable and Cell-Penetrating Peptide","volume":"57","author":"Ildefonso","year":"2016","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.neuroscience.2015.07.057","article-title":"17beta-Estradiol up-regulates Nrf2 via PI3K\/AKT and estrogen receptor signaling pathways to suppress light-induced degeneration in rat retina","volume":"304","author":"Zhu","year":"2015","journal-title":"Neuroscience"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1167\/iovs.07-1099","article-title":"Essential roles of the PI3 kinase\/Akt pathway in regulating Nrf2-dependent antioxidant functions in the RPE","volume":"49","author":"Wang","year":"2008","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1016\/j.bbrc.2017.12.078","article-title":"Activation of KGFR-Akt-mTOR-Nrf2 signaling protects human retinal pigment epithelium cells from Ultra-violet","volume":"495","author":"Hu","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1111\/febs.15485","article-title":"Structural insights into the multiple binding modes of Dimethyl Fumarate (DMF) and its analogs to the Kelch domain of Keap1","volume":"288","author":"Unni","year":"2021","journal-title":"FEBS J."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jneuroim.2016.08.006","article-title":"Dimethyl fumarate alters microglia phenotype and protects neurons against proinflammatory toxic microenvironments","volume":"299","author":"Peng","year":"2016","journal-title":"J. Neuroimmunol."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Rosito, M., Testi, C., Parisi, G., Cortese, B., Baiocco, P., and Di Angelantonio, S. (2020). Exploring the Use of Dimethyl Fumarate as Microglia Modulator for Neurodegenerative Diseases Treatment. Antioxidants, 9.","DOI":"10.3390\/antiox9080700"},{"key":"ref_95","first-page":"1927","article-title":"Effect of dietary inducer dimethylfumarate on glutathione in cultured human retinal pigment epithelial cells","volume":"40","author":"Nelson","year":"1999","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1167\/iovs.18-24398","article-title":"Monomethyl Fumarate Protects the Retina From Light-Induced Retinopathy","volume":"60","author":"Jiang","year":"2019","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Dietrich, M., Hecker, C., Nasiri, M., Samsam, S., Issberner, A., Kohne, Z., Hartung, H.P., and Albrecht, P. (2020). Neuroprotective Properties of Dimethyl Fumarate Measured by Optical Coherence Tomography in Non-inflammatory Animal Models. Front. Neurol., 11.","DOI":"10.3389\/fneur.2020.601628"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1515\/revneuro-2023-0130","article-title":"An overview of retinal light damage models for preclinical studies on age-related macular degeneration: Identifying molecular hallmarks and therapeutic targets","volume":"35","author":"Carozza","year":"2024","journal-title":"Rev. Neurosci."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa1114287","article-title":"Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis","volume":"367","author":"Gold","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.neuron.2018.01.021","article-title":"Multiple Sclerosis: Mechanisms and Immunotherapy","volume":"97","author":"Kaskow","year":"2018","journal-title":"Neuron"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.4049\/jimmunol.1601532","article-title":"Dimethyl Fumarate Selectively Reduces Memory T Cells and Shifts the Balance between Th1\/Th17 and Th2 in Multiple Sclerosis Patients","volume":"198","author":"Wu","year":"2017","journal-title":"J. Immunol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/1352458520949158","article-title":"Progressive multifocal leukoencephalopathy in dimethyl fumarate-treated multiple sclerosis patients","volume":"28","author":"Jordan","year":"2022","journal-title":"Mult. Scler."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Schloder, J., Berges, C., Luessi, F., and Jonuleit, H. (2017). Dimethyl Fumarate Therapy Significantly Improves the Responsiveness of T Cells in Multiple Sclerosis Patients for Immunoregulation by Regulatory T Cells. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18020271"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Manai, F., Govoni, S., and Amadio, M. (2022). The Challenge of Dimethyl Fumarate Repurposing in Eye Pathologies. Cells, 11.","DOI":"10.3390\/cells11244061"},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Bresciani, G., Manai, F., Davinelli, S., Tucci, P., Saso, L., and Amadio, M. (2023). Novel potential pharmacological applications of dimethyl fumarate-an overview and update. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1264842"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1089\/ars.2015.6622","article-title":"Pharmacodynamics of Dimethyl Fumarate Are Tissue Specific and Involve NRF2-Dependent and -Independent Mechanisms","volume":"24","author":"Brennan","year":"2016","journal-title":"Antioxid. Redox Signal"},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Tossetta, G., Fantone, S., Togni, L., Santarelli, A., Olivieri, F., Marzioni, D., and Rippo, M.R. (2024). Modulation of NRF2\/KEAP1 Signaling by Phytotherapeutics in Periodontitis. Antioxidants, 13.","DOI":"10.3390\/antiox13101270"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.62347\/LZVO6743","article-title":"Nrf2 in human cancers: Biological significance and therapeutic potential","volume":"14","author":"Tian","year":"2024","journal-title":"Am. J. Cancer Res."},{"key":"ref_109","unstructured":"Agency, E.M. (2025, April 22). Tecfidera: EPAR\u2014Product Information. Available online: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/tecfidera#product-info."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.msard.2017.01.006","article-title":"Classifying PML risk with disease modifying therapies","volume":"12","author":"Berger","year":"2017","journal-title":"Mult. Scler. Relat. Disord."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/13\/6112\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:58:38Z","timestamp":1760032718000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/13\/6112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,25]]},"references-count":110,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["ijms26136112"],"URL":"https:\/\/doi.org\/10.3390\/ijms26136112","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,25]]}}}